NeuroSense Therapeutics Announces Receipt of Nasdaq Notifications Regarding Minimum Bid Price and Market Value Requirements
April 3, 2026
Technology
-
-
MiNK Therapeutics and Memorial Sloan Kettering to Present Phase II Study of agenT-797 Combination in PD-1 Refractory Gastroesophageal Cancer at AACR 2026
April 3, 2026
-
BioCardia Files Request for Meeting With FDA to Discuss Accelerated Approval Pathway for CardiAMP® System in Ischemic Heart Failure
April 2, 2026
-
Enterprises Align AI and Data Platforms to Scale AI Deployments with Accuracy, Compliance, ISG says
April 2, 2026
-
Global Counter-UAS Interceptor Market Surges Amid Escalating Drone Warfare Threats
April 2, 2026
-
INOVIO Announces Pricing of $17.5 Million Public Offering
April 2, 2026
-
Entera Bio Announces Pricing of $10.0 Million Direct Investment by BVF Partners with Potential for up to $24.5 Million in Total Proceeds
April 2, 2026
-
Oncotelic Therapeutics Announces Strategic Partnership with TechForce Robotics to Commercialize PDAOAI-Enhanced GMP Robotics Platform
April 2, 2026
-
Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update
April 2, 2026
-
Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies
April 2, 2026
-
Oncolytics Biotech® Completes Domicile Change to the United States
April 1, 2026
-
Treasure Global’s Subsidiary Tadaa Technologies Partners with Anhui Fuyuan Group to Accelerate Global Drone and Electric Mobility Expansion
April 1, 2026
-
Lotte Rental Speeds Growth and Innovation with Multiyear Partnership with Rimini Street
March 31, 2026
-
NeuroSense Therapeutics Reports Year End 2025 Financial Results and Provides Business Update
March 31, 2026
-
Dominari 2025 Revenue Surges 487% in 2025, Balance Sheet Strengthens Significantly
March 31, 2026
-
Defense Industry Disrupted as Drone-as-a-Service Market Accelerates Toward $100 Billion
March 31, 2026